Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen.
about
Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer.Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy.KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy.
P2860
Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Prognostic relevance of KRAS g ...... r FIr-B/FOx intensive regimen.
@ast
Prognostic relevance of KRAS g ...... r FIr-B/FOx intensive regimen.
@en
type
label
Prognostic relevance of KRAS g ...... r FIr-B/FOx intensive regimen.
@ast
Prognostic relevance of KRAS g ...... r FIr-B/FOx intensive regimen.
@en
prefLabel
Prognostic relevance of KRAS g ...... r FIr-B/FOx intensive regimen.
@ast
Prognostic relevance of KRAS g ...... r FIr-B/FOx intensive regimen.
@en
P2093
P2860
P356
P1476
Prognostic relevance of KRAS g ...... r FIr-B/FOx intensive regimen.
@en
P2093
Aldo Victor Giordano
Corrado Ficorella
Gemma Bruera
Katia Cannita
Roberto Vicentini
P2860
P304
P356
10.3892/IJO.2014.2369
P577
2014-04-04T00:00:00Z